BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 16549157)

  • 1. De novo glomerulonephritis in renal allografts with hepatitis C virus infection.
    Ozdemir BH; Ozdemir FN; Sezer S; Colak T; Haberal M
    Transplant Proc; 2006 Mar; 38(2):492-5. PubMed ID: 16549157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of recurrent glomerulonephritis on renal graft survival.
    Toledo K; Pérez-Sáez MJ; Navarro MD; Ortega R; Redondo MD; Agüera ML; Rodríguez-Benot A; Aljama P
    Transplant Proc; 2011; 43(6):2182-6. PubMed ID: 21839228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B and C markers in glomerular diseases.
    Enríquez R; Rodríguez JC; Sirvent AE; Amorós F; Ardoy F; Alvarez M; Royo G
    Scand J Urol Nephrol; 2007; 41(6):535-8. PubMed ID: 17853005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis.
    Requião-Moura LR; Moscoso-Solorzano GT; Franco MF; Ozaki KS; Pacheco-Silva A; Kirsztajn GM; Câmara NO
    Clin Transplant; 2007; 21(3):363-70. PubMed ID: 17488386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of de novo hepatitis C virus infection in heart transplant recipients.
    Ong JP; Barnes DS; Younossi ZM; Gramlich T; Yen-Lieberman B; Goormastic M; Sheffield C; Hoercher K; Starling R; Young J; Smedira N; McCarthy P
    Hepatology; 1999 Nov; 30(5):1293-8. PubMed ID: 10534352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis.
    Cao Y; Zhang Y; Wang S; Zou W
    Nephrol Dial Transplant; 2009 Sep; 24(9):2745-51. PubMed ID: 19377056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primer on recurrent and de novo glomerulonephritis in renal allografts.
    Ivanyi B
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival.
    Bestard O; Cruzado JM; Torras J; Gil-Vernet S; Serón D; Moreso F; Rama I; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3774-7. PubMed ID: 16386535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection and renal disease after renal transplantation.
    Morales JM
    Transplant Proc; 2004 Apr; 36(3):760-2. PubMed ID: 15110654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurent and de novo membranous glomerulopathy after kidney transplantation.
    Aline-Fardin A; Rifle G; Martin L; Justrabo E; Bour JB; D'Athis P; Tanter Y; Mousson C
    Transplant Proc; 2009 Mar; 41(2):669-71. PubMed ID: 19328952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV associated glomerulopathy in Egyptian patients: clinicopathological analysis.
    Sabry A; E-Agroudy A; Sheashaa H; El-Husseini A; Mohamed Taha N; Elbaz M; Sobh M
    Virology; 2005 Mar; 334(1):10-6. PubMed ID: 15749118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.
    Kamar N; Rostaing L; Boulestin A; Sandres K; Dubois M; Ribes D; Modesto A; Durand D; Izopet J
    J Med Virol; 2003 Apr; 69(4):482-8. PubMed ID: 12601755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection and de novo glomerular lesions in renal allografts.
    Cruzado JM; Carrera M; Torras J; Grinyó JM
    Am J Transplant; 2001 Jul; 1(2):171-8. PubMed ID: 12099366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of hepatitis C virus infection in renal transplant recipients.
    Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
    Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.
    Mirioglu S; Caliskan Y; Goksoy Y; Gulcicek S; Ozluk Y; Sarihan I; Seyahi N; Kilicaslan I; Turkmen A; Sever MS
    Int Urol Nephrol; 2017 Dec; 49(12):2265-2272. PubMed ID: 29039058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation.
    Schwarz A; Krause PH; Offermann G; Keller F
    Transplantation; 1994 Sep; 58(6):650-4. PubMed ID: 7940683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal allograft glomerulonephritis.
    Honkanen E; Törnroth T; Pettersson E; Kuhlbäck B
    Scand J Urol Nephrol Suppl; 1985; 90():23-7. PubMed ID: 3912981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplantation glomerulonephritis: risk factors associated with kidney allograft loss.
    Ostrowska J; Pazik J; Lewandowski Z; Mróz A; Perkowska-Ptasińska A; Durlik M
    Transplant Proc; 2007 Nov; 39(9):2751-3. PubMed ID: 18021977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of adult primary glomerular diseases: retrospective analysis of 206 kidney biopsies (1990-1993).
    Mazzarolo Cruz HM; Cruz J; Silva AL; Saldanha LB; de Oliveira Penna D
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(1):3-6. PubMed ID: 8762646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection after renal transplantation.
    Romero E; Galindo P; Bravo JA; Osorio JM; Pérez A; Baca Y; Ferreira C; Asensio C; Osuna A
    Transplant Proc; 2008 Nov; 40(9):2933-5. PubMed ID: 19010152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.